Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 73, Issue 11

Antifungal resistance, clinical outcome and clinico-microbiological correlation in ocular infections due to common melanized fungi and in South India No Access

Abstract

Melanized fungi were rarely studied for their antifungal resistance (AFR) or clinical outcome, despite rising incidence of melanized fungal ocular infections and AFR in general. We report the antifungal resistance patterns, clinical outcome and clinico-microbiological correlation in two commonly isolated melanized fungi from ocular infections, and , at a tertiary eyecare centre in South India.

. Despite melanized fungi accounting for a significant proportion of ocular fungal infections in the Indian subcontinent, and despite there being a limited selection of effective antifungal agents available for these infections, the existing data and studies on these issues remain sparse. Therefore, this study aimed to investigate the prevalence of antifungal resistance in two of the most common melanized fungal pathogens in ocular infections, and and correlate it with the treatment given and the clinical outcome in patients.

Electronic medical records provided the clinical data. Standard broth microdilution was performed for antifungal susceptibility testing (AFST) in 30 isolates (17 . and 13 . ) for amphotericin B and natamycin (polyenes): voriconazole, ketoconazole, posaconazole, itraconazole and fluconazole (azoles) and caspofungin (echinocandin). Multidrug resistance (MDR) was defined as resistance to more than or equal to two classes of antifungals. DNA sequencing was performed for the isolates for species confirmation. The multivariate analysis was done for determining poor prognostic factors.

AFST showed highest susceptibility of study isolates for voriconazole (83.3% isolates), followed by natamycin (80%), fluconazole (80%), itraconazole (76.7%), ketoconazole (70%), posaconazole (66.7%), caspofungin (66.7%) and lastly amphotericin B (63.3%). All patients empirically received topical natamycin; additional oral ketoconazole/intraocular voriconazole was administered in select few. MDR was strongly associated with poor clinical outcome (multivariate analysis: = 0.03, odds ratio = 7.8). All patients had microbial keratitis, one progressed to endophthalmitis. Additionally, therapeutic penetrating keratoplasty was required in 40% of cases. Globe salvage was possible in 80% patients, though good visual outcome was seen in only half of them. Both, anatomical and visual outcomes, were poor in 20% of patients. DNA sequencing showed as the highest study species.

and showed varying antifungal susceptibility and clinical outcome in ocular infections. Voriconazole had significantly higher activity, while amphotericin B had lower activity for these melanized fungi. MDR isolates showed poorer clinical outcome.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antifungal resistance , antifungal susceptibility , broth microdilution , C. lunata , dematiaceous fungi , L. theobromae , melanized fungi and ocular fungal infections
Funding
This study was supported by the:
  • Hyderabad Eye Research Foundation (Award LEC-BHR-P-12-21-776)
    • Principal Award Recipient: NotApplicable
© 2024 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001924
2024-11-07
2025-12-06

Metrics

Loading full text...

Full text loading...

References

  1. Kainz K, Bauer MA, Madeo F, Carmona-Gutierrez D. Fungal infections in humans: the silent crisis. Microb Cell 2020; 7:143–145 [View Article] [PubMed]
     [Google Scholar]
  2. Prajna VN, Prajna L, Muthiah S. Fungal keratitis: the Aravind experience. Indian J Ophthalmol 2017; 65:912–919 [View Article] [PubMed]
     [Google Scholar]
  3. Das T, Agarwal M, Anand AR, Behera UC, Bhende M et al. Fungal endophthalmitis: analysis of 730 consecutive eyes from 7 tertiary eye care centers in India. Ophthalmol Retina 2022; 6:243–251 [View Article] [PubMed]
     [Google Scholar]
  4. Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol 2022; 20:557–571 [View Article] [PubMed]
     [Google Scholar]
  5. Ganguly S, Salma KC, Kansakar I, Sharma M, Bastola P et al. Pattern of fungal isolates in cases of corneal ulcer in the western periphery of Nepal. Nepal J Ophthalmol 2011; 3:118–122 [View Article] [PubMed]
     [Google Scholar]
  6. Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000; 107:574–580 [View Article] [PubMed]
     [Google Scholar]
  7. Mythili A, Shobana CS, Krizsán K, Hassan AS, Sangeetha AB et al. Molecular identification, phylogeny and antifungal susceptibilities of dematiaceous fungi isolated from human keratomycosis. J Infect Public Health 2023; 16:25–33 [View Article] [PubMed]
     [Google Scholar]
  8. Wilhelmus KR, Jones DB. Curvularia keratitis. Trans Am Ophthalmol Soc 2001; 99:111–130 [PubMed]
     [Google Scholar]
  9. Prajna NV, Lalitha P, Krishnan T, Rajaraman R, Radnakrishnan N et al. Patterns of antifungal resistance in adult patients with fungal keratitis in south India: a post hoc analysis of 3 randomized clinical trials. JAMA Ophthalmol 2022; 140:179–184 [View Article] [PubMed]
     [Google Scholar]
  10. Mitra S, Chandran K, Fernandes M. Practical tips and common mistakes in ocular microbiology sampling and processing. Indian J Ophthalmol 2023; 71:1698–1705 [View Article]
     [Google Scholar]
  11. CLSI Reference Method for Broth Dilution of Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard- M38-Edition 3 Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2017
     [Google Scholar]
  12. Aberkane A, Cuenca-Estrella M, Gomez-Lopez A, Petrikkou E, Mellado E et al. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother 2002; 50:719–722 [View Article] [PubMed]
     [Google Scholar]
  13. Clinical and Laboratory Standards Institute Performance Standards for Antifungal Susceptibility Testing for Filamentous Fungi. Approved Standard M61- Edition 1 Wayne, USA: Clinical and Laboratory Standards Institute; 2017
     [Google Scholar]
  14. Lalitha P, Vijaykumar R, Prajna NV, Fothergill AW. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. J Clin Microbiol 2008; 46:3477–3478 [View Article] [PubMed]
     [Google Scholar]
  15. Arastehfar A, Gabaldón T, Garcia-Rubio R, Jenks JD, Hoenigl M et al. Drug-resistant fungi: an emerging challenge threatening our limited antifungal Armamentarium. Antibiotics 2020; 9:877 [View Article] [PubMed]
     [Google Scholar]
  16. Morschhäuser J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 2010; 47:94–106 [View Article] [PubMed]
     [Google Scholar]
  17. Gow NAR, Johnson C, Berman J, Coste AT, Cuomo CA et al. The importance of antimicrobial resistance in medical mycology. Nat Commun 2022; 13:5352 [View Article] [PubMed]
     [Google Scholar]
  18. White TJ, Bruns T, Lee S. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications. In PCR - Protocols and Applications - A Laboratory Manual vol 18 Academic Press; 1990 pp 315–322 [View Article]
     [Google Scholar]
  19. Mitra S, Basu S, Rath S, Sahu SK. Colistin resistance in Gram-negative ocular infections: prevalence, clinical outcome and antibiotic susceptibility patterns. Int Ophthalmol 2020; 40:1307–1317 [View Article] [PubMed]
     [Google Scholar]
  20. Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect 2013; 19:210–220 [View Article] [PubMed]
     [Google Scholar]
  21. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 2008; 115:1501–1507 [View Article] [PubMed]
     [Google Scholar]
  22. Lupia T, Corcione S, Fea AM, Reibaldi M, Fallico M et al. Exogenous fungal endophthalmitis: clues to Aspergillus aetiology with a pharmacological perspective. Microorganisms 2020; 9:74 [View Article] [PubMed]
     [Google Scholar]
  23. Thomas PA. Fungal infections of the cornea. Eye 2003; 17:852–862 [View Article] [PubMed]
     [Google Scholar]
  24. Xuguang S, Zhixin W, Zhiqun W, Shiyun L, Ran L. Ocular fungal isolates and antifungal susceptibility in northern China. Am J Ophthalmol 2007; 143:131–133 [View Article] [PubMed]
     [Google Scholar]
  25. Ozdemir HG, Oz Y, Ilkit M, Kiraz N. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin. Med Mycol 2012; 50:130–135 [View Article] [PubMed]
     [Google Scholar]
  26. Koss T, Bagheri B, Zeana C, Romagnoli MF, Grossman ME. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent. J Am Acad Dermatol 2002; 46:945–947 [View Article] [PubMed]
     [Google Scholar]
  27. Zhang C, Cheng J, Jiang Y, Liu J. Application of caspofungin in China compared with amphotericin B and fluconazole. Ther Clin Risk Manag 2014; 10:737–741 [View Article] [PubMed]
     [Google Scholar]
  28. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 2015; 41:285–295 [View Article] [PubMed]
     [Google Scholar]
  29. Chakrabarti A, Shivaprakash MR, Singh R, Tarai B, George VK et al. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina 2008; 28:1400–1407 [View Article] [PubMed]
     [Google Scholar]
  30. Trinh T, Emami S, Gould J, Mimouni M, Cohen E et al. Clinical and microbiological analysis of fungal keratitis in Toronto, Canada: a 20-year study. Med Mycol 2022; 60:myac047 [View Article] [PubMed]
     [Google Scholar]
  31. Zhao J, Cheng Y, Song X, Wang C, Su G et al. A comparative treatment study of intravitreal voriconazole and liposomal amphotericin B in an Aspergillus fumigatus endophthalmitis model. Invest Ophthalmol Vis Sci 2015; 56:7369–7376 [View Article] [PubMed]
     [Google Scholar]
  32. Lestrade PPA, Meis JF, Melchers WJG, Verweij PE. Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management. Clin Microbiol Infect 2019; 25:799–806 [View Article] [PubMed]
     [Google Scholar]
  33. Lestrade PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, van der Velden WJFM et al. Voriconazole resistance and mortality in invasive Aspergillosis: a multicenter retrospective cohort study. Clin Infect Dis 2019; 68:1463–1471 [View Article] [PubMed]
     [Google Scholar]
  34. Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 Suppl 1:e1–e38 [View Article] [PubMed]
     [Google Scholar]
  35. Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol 2020; 18:319–331 [View Article] [PubMed]
     [Google Scholar]
  36. Borderie VM, Bourcier TM, Poirot JL, Baudrimont M, Prudhomme de Saint-Maur P et al. Endophthalmitis after Lasiodiplodia theobromae corneal abscess. Graefes Arch Clin Exp Ophthalmol 1997; 235:259–261 [View Article] [PubMed]
     [Google Scholar]
  37. Hamerski C, Proia AD. Lasiodiplodia theobromae keratitis: a rare tropical fungal keratitis in a non-tropical climate. Am J Ophthalmol Case Rep 2023; 32:101944 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001924
Loading
Antifungal resistance, clinical outcome and clinico-microbiological correlation in ocular infections due to common melanized fungi Curvularia lunata and Lasiodiplodia theobromae in South India
J. Med. Microbiol. 73, 001924 (2024); https://doi.org/10.1099/jmm.0.001924
/content/journal/jmm/10.1099/jmm.0.001924
/content/journal/jmm/10.1099/jmm.0.001924
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error